218 related articles for article (PubMed ID: 31695785)
1. The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis.
Kumar V; Dong Y; Kumar V; Almawash S; Mahato RI
Theranostics; 2019; 9(25):7537-7555. PubMed ID: 31695785
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice.
Dutta R; Kumar V; Peng Y; Evande RE; Grem JL; Mahato RI
Pharm Res; 2017 Mar; 34(3):564-578. PubMed ID: 27995525
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis.
Kumar V; Mondal G; Dutta R; Mahato RI
Biomaterials; 2016 Jan; 76():144-56. PubMed ID: 26524535
[TBL] [Abstract][Full Text] [Related]
4. Polymeric Micellar Delivery of Novel Microtubule Destabilizer and Hedgehog Signaling Inhibitor for Treating Chemoresistant Prostate Cancer.
Yang R; Chen H; Guo D; Dong Y; Miller DD; Li W; Mahato RI
J Pharmacol Exp Ther; 2019 Sep; 370(3):864-875. PubMed ID: 30996033
[TBL] [Abstract][Full Text] [Related]
5. Blood-Stage Plasmodium Berghei ANKA Infection Promotes Hepatic Fibrosis by Enhancing Hedgehog Signaling in Mice.
Kim J; Wang S; Lee C; Sung S; Shin Y; Song KS; Cha HJ; Ock M; Jung Y
Cell Physiol Biochem; 2018; 50(4):1414-1428. PubMed ID: 30355912
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis.
Kumar V; Mundra V; Mahato RI
Pharm Res; 2014 May; 31(5):1158-69. PubMed ID: 24249038
[TBL] [Abstract][Full Text] [Related]
7. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer.
Kumar V; Mondal G; Slavik P; Rachagani S; Batra SK; Mahato RI
Mol Pharm; 2015 Apr; 12(4):1289-98. PubMed ID: 25679326
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Potential of OMe-PS-miR-29b1 for Treating Liver Fibrosis.
Kumar V; Kumar V; Luo J; Mahato RI
Mol Ther; 2018 Dec; 26(12):2798-2811. PubMed ID: 30287074
[TBL] [Abstract][Full Text] [Related]
9. Micelle Mixtures for Coadministration of Gemcitabine and GDC-0449 To Treat Pancreatic Cancer.
Karaca M; Dutta R; Ozsoy Y; Mahato RI
Mol Pharm; 2016 Jun; 13(6):1822-32. PubMed ID: 26981724
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling.
Pratap A; Singh S; Mundra V; Yang N; Panakanti R; Eason JD; Mahato RI
J Drug Target; 2012 Nov; 20(9):770-82. PubMed ID: 22994359
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice.
Kumar V; Mundra V; Peng Y; Wang Y; Tan C; Mahato RI
Theranostics; 2018; 8(15):4033-4049. PubMed ID: 30128034
[No Abstract] [Full Text] [Related]
13. Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis.
Feng J; Wang C; Liu T; Li J; Wu L; Yu Q; Li S; Zhou Y; Zhang J; Chen J; Ji J; Chen K; Mao Y; Wang F; Dai W; Fan X; Wu J; Guo C
J Cell Mol Med; 2019 Sep; 23(9):6479-6493. PubMed ID: 31328391
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer.
Philips GM; Chan IS; Swiderska M; Schroder VT; Guy C; Karaca GF; Moylan C; Venkatraman T; Feuerlein S; Syn WK; Jung Y; Witek RP; Choi S; Michelotti GA; Rangwala F; Merkle E; Lascola C; Diehl AM
PLoS One; 2011; 6(9):e23943. PubMed ID: 21912653
[TBL] [Abstract][Full Text] [Related]
15. Anti-miR-96 and Hh pathway inhibitor MDB5 synergistically ameliorate alcohol-associated liver injury in mice.
Kumar V; Sethi B; Staller DW; Xin X; Ma J; Dong Y; Talmon GA; Mahato RI
Biomaterials; 2023 Apr; 295():122049. PubMed ID: 36827892
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats.
Yang J; Hou Y; Ji G; Song Z; Liu Y; Dai G; Zhang Y; Chen J
Eur J Pharm Sci; 2014 Feb; 52():180-90. PubMed ID: 24296297
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer.
Kumar V; Chaudhary AK; Dong Y; Zhong HA; Mondal G; Lin F; Kumar V; Mahato RI
Sci Rep; 2017 May; 7(1):1665. PubMed ID: 28490735
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model.
Thomas RG; Moon MJ; Kim JH; Lee JH; Jeong YY
PLoS One; 2015; 10(12):e0145512. PubMed ID: 26714035
[TBL] [Abstract][Full Text] [Related]
19. Deoxyelephantopin suppresses hepatic stellate cells activation associated with inhibition of aerobic glycolysis via hedgehog pathway.
Gao W; Sun J; Wang F; Lu Y; Wen C; Bian Q; Wu H
Biochem Biophys Res Commun; 2019 Sep; 516(4):1222-1228. PubMed ID: 31296386
[TBL] [Abstract][Full Text] [Related]
20. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis.
Choi SS; Omenetti A; Witek RP; Moylan CA; Syn WK; Jung Y; Yang L; Sudan DL; Sicklick JK; Michelotti GA; Rojkind M; Diehl AM
Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1093-106. PubMed ID: 19815628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
